Back to top

Image: Bigstock

Surging Earnings Estimates Signal Good News for Hecla Mining (HL)

Read MoreHide Full Article

Hecla Mining Company (HL - Free Report) is a leading low-cost U.S. silver producer and a growing gold producer that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on HL's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Hecla Mining could be a solid choice for investors.

Current Quarter Estimates for HL

In the past 30 days, two estimates have gone higher for Hecla Mining while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss 3 cents a share 30 days ago, to a loss of 2 cents today, a move of 33.3%.

Current Year Estimates for HL

Meanwhile, Hecla Mining's current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 13 cents per share 30 days ago to a loss of 12 cents per share today, an increase of 7.7%.

Hecla Mining Company Price and Consensus

Hecla Mining Company Price and Consensus

Hecla Mining Company price-consensus-chart | Hecla Mining Company Quote

Bottom Line

The stock has also started to move higher lately, adding 8.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So, investors may want to consider this Zacks Rank #3 (Hold) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Hecla Mining Company (HL) - free report >>

Published in